Tohoku University
Sendai, Japan
NCT Number: NCT00333372
To Evaluate the efficacy of Z-338 in subjects with Functional Dyspepsia, focusing on the assessment of subjective symptoms in order to further determine the optimal dosage and efficacy parameters for PhaseIII clinical trials.
Looking for future studies?
Notify Me20 year–79 year
All sexes
Interventional
Phase 2
Sendai, Japan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Zeria Pharmaceutical
Industry
To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia, Focusing on the Assessment of Subjective Symptoms
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06732453
Digestive System Diseases, Functional Dyspepsia
Charlotte, North Carolina, United States
View Trial DetailsNCT04526119
Functional Dyspepsia
Matsumoto, Nagano, Japan
View Trial DetailsNCT05513040
Functional Dyspepsia
Lanzhou, Gansu, China
View Trial DetailsNCT03176927
Chronic Nausea, Diabetic Gastroparesis
Nashville, Tennessee, United States
View Trial Details